Randomized Clinical Assay for Hepatic Grafts Preservation With University of Wisconsin or Histidine-Tryptophan-Ketoglutarate Solutions in Liver Transplantion

Transplantation Proceedings

Volumn 38, Issue 6, 2006, Pages 1872-1875

  Meine, M H ^a   Zanotelli, M L ^a   Neumann, J ^a   Kiss, G ^a   de Jesus Grezzana, T ^a   Leipnitz, I ^a   Schlindwein, E S ^a   Fleck Jr , A ^a   Gleisner, A L ^a   de Mello Brandao A ^a   Marroni, C A ^a   Cantisani, G P C ^a  

^a Liver Transplantation Group   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXOGLUTARIC ACID; ADRENERGIC RECEPTOR STIMULATING AGENT; HISTIDINE; TRYPTOPHAN; UNIVERSITY OF WISCONSIN SOLUTION;

ADULT; AGE; ARTICLE; BILIARY TRACT DISEASE; CONTROLLED STUDY; COST; FATTY LIVER; FEMALE; GRAFT DYSFUNCTION; GRAFT PRESERVATION; HEMODYNAMICS; HUMAN; LIVER; LIVER CIRRHOSIS; LIVER FAILURE; LIVER GRAFT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; RACE; RECIPIENT; RETRANSPLANTATION; SEX;

ADENOSINE; ADULT; ALLOPURINOL; FEMALE; GLUTATHIONE; GRAFT SURVIVAL; HISTIDINE; HUMANS; INSULIN; LIVER; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; RAFFINOSE; SURVIVAL RATE; TREATMENT OUTCOME; TRYPTOPHAN;

EID: 33747057413     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.06.071     Document Type: Article

References (12)

1. Kalayoglu M., Sollinger H.W., Stratta R.J., et al. Extended preservation of the liver for clinical transplantation. Lancet 1 (1988) 617
2. Belzer F.O., Kalayoglu M., D'Alessandro A.M., et al. Organ preservation. experience with University of Wisconsin solution and plans for the future. Clin Transplant 4 (1990) 73
3. Adam R., Bismuth H., and Diamond T. Effect of extended cold ischemia with UW solution on graft function after liver transplantation. Lancet 340 (1992) 1373
4. Lange R., Erhard J., Rauen U., et al. Hepatocellular injury during preservation of human livers with UW and HTK solution. Transplant Proc 29 (1997) 400
5. Muhlbacher F., Langer F., and Mittermayer C. Preservation solutions for transplantation. Transplant Proc 31 (1999) 2069
6. Sanchez-Urdazpal L., Gores G.J., Ward E.M., et al. Ischemic-type biliary complications after orthotopic liver transplantation. Hepatology 16 (1992) 49
7. Kadmon M., Bleyl J., Kuppers B., et al. Biliary complications after prolonged University of Wisconsin preservation of liver allografts. Transplant Proc 25 (1993) 1651
8. Cutrin J.C., Cantino D., Biasi F., et al. Reperfusion damage to the bile canaliculi in transplanted human liver. Hepatology 24 (1996) 1053
9. Gubernatis G., Pichlmayr R., Lamesch P., et al. HTK-solution (Bretschneider) for human liver transplantation. First clinical experiences. Langenbecks Arch Chir 375 (1990) 66
10. Holscher M., and Groenewoud A.F. Current status of the HTK solution of Bretschneider in organ preservation. Transplant Proc 23 (1991) 2334
11. Canelo R., Hakim N.S., and Ringe B. Experience with hystidine tryptophan ketoglutarate versus University Wisconsin preservation solutions in transplantation. Int Surg 88 (2003) 145
12. Pokorny H., Rasoul-Rockenschaub S., Langer F., et al. Histidine-tryptophan-ketoglutarate solution for organ preservation in human liver transplantation-a prospective multi-centre observation study. Transpl Int 17 (2004) 256